Generation of Skeletal Myogenic Progenitors from Human Pluripotent Stem Cells Using Non-viral Delivery of Minicircle DNA
Overview
Affiliations
Currently, the most efficient and promising approach for generating large numbers of engraftable human skeletal myogenic progenitors from pluripotent stem cells requires the conditional in vitro overexpression of PAX7 using lentiviral vectors. Because a non-integrating approach would be preferable to eliminate or minimize the risk associated with random genomic integration, here we investigate whether transient expression of PAX7 using minicircle DNA would enable the generation of functional pluripotent stem cell-derived myogenic progenitors, equivalent to those generated by lentivirus. Our results demonstrate that upon multiple transfections, the minicircle approach allows for the scalable generation of myogenic progenitors and these undergo efficient terminal differentiation in vitro. However, transplantation of minicircle-generated myogenic progenitors resulted in limited engraftment. This is probably due to less efficient delivery and more transient PAX7 expression in these cultures since PAX7 downregulation is accompanied by high level of spontaneous differentiation. Thus, although the in vitro data shows that the minicircle approach could potentially replace the use of lentivirus, improvements in the transfection/expression system will be necessary before it will be a feasible strategy for the generation of myogenic progenitors for cell replacement therapy.
Multitasking muscle: engineering iPSC-derived myogenic progenitors to do more.
Hamer M, Rossi F Front Cell Dev Biol. 2025; 12:1526635.
PMID: 39911186 PMC: 11794491. DOI: 10.3389/fcell.2024.1526635.
Challenges and Considerations of Preclinical Development for iPSC-Based Myogenic Cell Therapy.
Sun C, Serra C, Kalicharan B, Harding J, Rao M Cells. 2024; 13(7.
PMID: 38607035 PMC: 11011706. DOI: 10.3390/cells13070596.
Recapitulating human myogenesis ex vivo using human pluripotent stem cells.
Chien P, Xi H, Pyle A Exp Cell Res. 2022; 411(2):112990.
PMID: 34973262 PMC: 8996775. DOI: 10.1016/j.yexcr.2021.112990.
Improving therapeutic potential of non-viral minimized DNA vectors.
Arevalo-Soliz L, Hardee C, Fogg J, Corman N, Noorbakhsh C, Zechiedrich L Cell Gene Ther Insights. 2021; 6(10):1489-1505.
PMID: 33953961 PMC: 8095377. DOI: 10.18609/cgti.2020.163.
Human muscle production in vitro from pluripotent stem cells: Basic and clinical applications.
Yan L, Rodriguez-delaRosa A, Pourquie O Semin Cell Dev Biol. 2021; 119:39-48.
PMID: 33941447 PMC: 8530835. DOI: 10.1016/j.semcdb.2021.04.017.